Immunologic Significance of CD80/CD86 or Major Histocompatibility Complex-II Expression in Thymic Epithelial Tumors

INTRODUCTION: Unresectable or recurrent thymic epithelial tumors (TETs) have a poor prognosis, and treatment options are limited. This study aimed to investigate the immunologic significance of CD80/CD86 or major histocompatibility complex class II (MHC-II) expression in TETs, as potential predictiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikeda, Hideki, Nagasaki, Joji, Shimizu, Daiki, Katsuya, Yuki, Horinouchi, Hidehito, Hosomi, Yukio, Tanji, Etsuko, Iwata, Takekazu, Itami, Makiko, Kawazu, Masahito, Ohe, Yuichiro, Suzuki, Takuji, Togashi, Yosuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550405/
https://www.ncbi.nlm.nih.gov/pubmed/37799325
http://dx.doi.org/10.1016/j.jtocrr.2023.100573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550405/
https://www.ncbi.nlm.nih.gov/pubmed/37799325
http://dx.doi.org/10.1016/j.jtocrr.2023.100573

Ejemplares similares